204 related articles for article (PubMed ID: 16951384)
1. Antibody targeting to a class I MHC-peptide epitope promotes tumor cell death.
Wittman VP; Woodburn D; Nguyen T; Neethling FA; Wright S; Weidanz JA
J Immunol; 2006 Sep; 177(6):4187-95. PubMed ID: 16951384
[TBL] [Abstract][Full Text] [Related]
2. TCR mimic monoclonal antibody targets a specific peptide/HLA class I complex and significantly impedes tumor growth in vivo using breast cancer models.
Verma B; Neethling FA; Caseltine S; Fabrizio G; Largo S; Duty JA; Tabaczewski P; Weidanz JA
J Immunol; 2010 Feb; 184(4):2156-65. PubMed ID: 20065111
[TBL] [Abstract][Full Text] [Related]
3. TCR mimic monoclonal antibodies induce apoptosis of tumor cells via immune effector-independent mechanisms.
Verma B; Jain R; Caseltine S; Rennels A; Bhattacharya R; Markiewski MM; Rawat A; Neethling F; Bickel U; Weidanz JA
J Immunol; 2011 Mar; 186(5):3265-76. PubMed ID: 21282517
[TBL] [Abstract][Full Text] [Related]
4. Assessing vaccine potency using TCRmimic antibodies.
Neethling FA; Ramakrishna V; Keler T; Buchli R; Woodburn T; Weidanz JA
Vaccine; 2008 Jun; 26(25):3092-102. PubMed ID: 18353510
[TBL] [Abstract][Full Text] [Related]
5. Direct discovery and validation of a peptide/MHC epitope expressed in primary human breast cancer cells using a TCRm monoclonal antibody with profound antitumor properties.
Verma B; Hawkins OE; Neethling FA; Caseltine SL; Largo SR; Hildebrand WH; Weidanz JA
Cancer Immunol Immunother; 2010 Apr; 59(4):563-73. PubMed ID: 19779714
[TBL] [Abstract][Full Text] [Related]
6. Recruitment of CTL activity by tumor-specific antibody-mediated targeting of single-chain class I MHC-peptide complexes.
Lev A; Novak H; Segal D; Reiter Y
J Immunol; 2002 Sep; 169(6):2988-96. PubMed ID: 12218113
[TBL] [Abstract][Full Text] [Related]
7. Direct phenotypic analysis of human MHC class I antigen presentation: visualization, quantitation, and in situ detection of human viral epitopes using peptide-specific, MHC-restricted human recombinant antibodies.
Cohen CJ; Sarig O; Yamano Y; Tomaru U; Jacobson S; Reiter Y
J Immunol; 2003 Apr; 170(8):4349-61. PubMed ID: 12682272
[TBL] [Abstract][Full Text] [Related]
8. Selective targeting of melanoma and APCs using a recombinant antibody with TCR-like specificity directed toward a melanoma differentiation antigen.
Denkberg G; Lev A; Eisenbach L; Benhar I; Reiter Y
J Immunol; 2003 Sep; 171(5):2197-207. PubMed ID: 12928363
[TBL] [Abstract][Full Text] [Related]
9. Targeting TARP, a novel breast and prostate tumor-associated antigen, with T cell receptor-like human recombinant antibodies.
Epel M; Carmi I; Soueid-Baumgarten S; Oh S; Bera T; Pastan I; Berzofsky J; Reiter Y
Eur J Immunol; 2008 Jun; 38(6):1706-20. PubMed ID: 18446790
[TBL] [Abstract][Full Text] [Related]
10. Opportunities and challenges for TCR mimic antibodies in cancer therapy.
Chang AY; Gejman RS; Brea EJ; Oh CY; Mathias MD; Pankov D; Casey E; Dao T; Scheinberg DA
Expert Opin Biol Ther; 2016 Aug; 16(8):979-87. PubMed ID: 27094818
[TBL] [Abstract][Full Text] [Related]
11. Levels of specific peptide-HLA class I complex predicts tumor cell susceptibility to CTL killing.
Weidanz JA; Nguyen T; Woodburn T; Neethling FA; Chiriva-Internati M; Hildebrand WH; Lustgarten J
J Immunol; 2006 Oct; 177(8):5088-97. PubMed ID: 17015692
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive mutagenesis identifies the peptide repertoire of a p53 T-cell receptor mimic antibody that displays no toxicity in mice transgenic for human HLA-A*0201.
Trenevska I; Anderson AP; Bentley C; Hassanali T; Wiblin S; Maguire S; Pezzella F; Banham AH; Li D
PLoS One; 2021; 16(4):e0249967. PubMed ID: 33836029
[TBL] [Abstract][Full Text] [Related]
13. MHC allele-specific molecular features determine peptide/HLA-A2 conformations that are recognized by HLA-A2-restricted T cell receptors.
Wang Z; Turner R; Baker BM; Biddison WE
J Immunol; 2002 Sep; 169(6):3146-54. PubMed ID: 12218132
[TBL] [Abstract][Full Text] [Related]
14. Direct detection and quantitation of a distinct T-cell epitope derived from tumor-specific epithelial cell-associated mucin using human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells.
Cohen CJ; Hoffmann N; Farago M; Hoogenboom HR; Eisenbach L; Reiter Y
Cancer Res; 2002 Oct; 62(20):5835-44. PubMed ID: 12384546
[TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells directed toward the widely expressed tumor T-cell epitopes of the telomerase catalytic subunit.
Lev A; Denkberg G; Cohen CJ; Tzukerman M; Skorecki KL; Chames P; Hoogenboom HR; Reiter Y
Cancer Res; 2002 Jun; 62(11):3184-94. PubMed ID: 12036932
[TBL] [Abstract][Full Text] [Related]
16. TCR-like antibodies mediate complement and antibody-dependent cellular cytotoxicity against Epstein-Barr virus-transformed B lymphoblastoid cells expressing different HLA-A*02 microvariants.
Lai J; Choo JAL; Tan WJ; Too CT; Oo MZ; Suter MA; Mustafa FB; Srinivasan N; Chan CEZ; Lim AGX; Zhong Y; Chan SH; Hanson BJ; Gascoigne NRJ; MacAry PA
Sci Rep; 2017 Aug; 7(1):9923. PubMed ID: 28855662
[TBL] [Abstract][Full Text] [Related]
17. Tax and M1 peptide/HLA-A2-specific Fabs and T cell receptors recognize nonidentical structural features on peptide/HLA-A2 complexes.
Biddison WE; Turner RV; Gagnon SJ; Lev A; Cohen CJ; Reiter Y
J Immunol; 2003 Sep; 171(6):3064-74. PubMed ID: 12960332
[TBL] [Abstract][Full Text] [Related]
18. Immunodominant West Nile Virus T Cell Epitopes Are Fewer in Number and Fashionably Late.
Kaabinejadian S; McMurtrey CP; Kim S; Jain R; Bardet W; Schafer FB; Davenport JL; Martin AD; Diamond MS; Weidanz JA; Hansen TH; Hildebrand WH
J Immunol; 2016 May; 196(10):4263-73. PubMed ID: 27183642
[TBL] [Abstract][Full Text] [Related]
19. Development of a T-cell receptor mimic antibody targeting a novel Wilms tumor 1-derived peptide and analysis of its specificity.
Kurosawa N; Midorikawa A; Ida K; Fudaba YW; Isobe M
Cancer Sci; 2020 Oct; 111(10):3516-3526. PubMed ID: 32770595
[TBL] [Abstract][Full Text] [Related]
20. Development and implementation of a direct detection, quantitation and validation system for class I MHC self-peptide epitopes.
Weidanz JA; Piazza P; Hickman-Miller H; Woodburn D; Nguyen T; Wahl A; Neethling F; Chiriva-Internati M; Rinaldo CR; Hildebrand WH
J Immunol Methods; 2007 Jan; 318(1-2):47-58. PubMed ID: 17134715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
